83 results
8-K
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
on securities laws and regulatory requirements, corporate governance matters, and financial transactions in the equity and debt markets. Prior to his
8-K
EX-99.1
CRVO
CervoMed Inc
20 May 24
CervoMed to Appoint William Elder as Chief Financial Officer
4:07pm
on securities laws and regulatory requirements, corporate governance matters, and financial transactions in the equity and debt markets. Prior to his time
8-K/A
EX-99.3
tv7r4
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.2
2gfnvi1owzsg1xh gxib
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
19pyfg aqq
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
425
pueukyl7j a0pzofq
3 Aug 23
Business combination disclosure
4:15pm
8-K
wmhdisl
3 Aug 23
Other Events
4:15pm
424B3
1n9r0b51
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
ooud4wyq
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
mxh5b9
10 May 23
Registration of securities issued in business combination transactions
9:56pm
8-K
EX-10.1
norzs1zwt5z
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
PRRN14A
kmghv0j0iqb5qta7
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFC14A
7g0tuyq81p8jy3syci22
5 Dec 22
Proxy in contested solicitation
5:12pm
PRRN14A
1k4qxuhaf2nqg
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm